-2.12%
-5.40%
11.40%
27.64%
-2.50%
-47.95%
-25.51%

Company Description

IP Group Plc is a private equity and venture capital firm specializing in seed, early stage, start-up, incubation, growth capital, and mature financing.The firm also provides seed capital financing to spin out companies from the universities.It seeks to invest in the life sciences, physical sciences, energy & renewables, medical equipment and supplies, healthcare, technology, cleantech, intellectual property, pharmaceuticals & biotechnology, information technology & communications, and chemicals & materials.


It also provides support for its university partners' intellectual property commercialization activities, as well as in the identification of intellectual property.It typically invests between Β£0.5 million ($0.75 million) and Β£1 million ($1.50 million) per investment.The firm prefers to takes equity positions in its portfolio companies.


IP Group Plc was founded in 2001 and is based in London, United Kingdom with additional offices in Wilmington, Delaware; London, United Kingdom; Oxford, United Kingdom; Hong Kong S.A.R., Hong Kong and Melbourne, Australia.

Market Data

Last Price 50.8
Change Percentage -2.12%
Open 50.6
Previous Close 51.9
Market Cap ( Millions) 492
Volume 2027364
Year High 56.2
Year Low 35.65
M A 50 50.67
M A 200 46.8

Financial Ratios

FCF Yield -3.05%
Dividend Yield 0.00%
ROE -19.85%
Debt / Equity 13.99%
Net Debt / EBIDTA -25.57%
Price To Book 0.48
Price Earnings Ratio -2.31
Price To FCF -32.77
Price To sales -2.31
EV / EBITDA -2.33

Business Breakdown

Expected Mid-Term Growth

Segment nΒ°1 -> Life Sciences

Expected Growth : 10.47 %

What the company do ?

Life Sciences from IP Group Plc refers to the development and commercialization of innovative healthcare and biotechnology products, including therapeutics, diagnostics, and medical devices.

Why we expect these perspectives ?

Strong demand for innovative healthcare solutions, increasing investment in R&D, and strategic partnerships drive growth in Life Sciences at IP Group Plc. The segment benefits from a robust pipeline of novel therapeutics, diagnostics, and medical devices, as well as a growing need for personalized medicine and gene editing technologies.

Segment nΒ°2 -> Other

Expected Growth : 10.27 %

What the company do ?

The 'Other' segment from IP Group Plc includes revenue from non-core activities, such as interest income and other miscellaneous income.

Why we expect these perspectives ?

IP Group Plc's 10.27% growth is driven by its diversified portfolio of intellectual property-based businesses, strong partnerships, and strategic investments in high-growth sectors such as cleantech, healthcare, and technology. Additionally, the company's focus on innovation, R&D, and commercialization of new technologies contributes to its growth momentum.

Segment nΒ°3 -> Oxford Nanopore

Expected Growth : 11.27 %

What the company do ?

Oxford Nanopore, a spin-out from University of Oxford, is a UK-based company that develops portable, real-time, and low-cost DNA sequencing technology.

Why we expect these perspectives ?

Oxford Nanopore's 11.27% growth is driven by increasing adoption of its portable, real-time DNA sequencing technology in research and clinical settings, coupled with expanding partnerships and collaborations, particularly in the Asia-Pacific region. Additionally, growing demand for precision medicine and genomic analysis, as well as strategic investments from IP Group Plc, contribute to the company's rapid growth.

Segment nΒ°4 -> Regenerative Future

Expected Growth : 10.27 %

What the company do ?

Regenerative Future from IP Group Plc is a sustainable investment strategy focusing on environmental and social impact, driving positive change through innovative technologies.

Why we expect these perspectives ?

Regenerative Future from IP Group Plc's 10.27% growth is driven by increasing demand for sustainable solutions, government incentives for eco-friendly technologies, and strategic investments in research and development. Additionally, the growing awareness of environmental issues and the need for renewable energy sources are contributing to the segment's rapid expansion.

Segment nΒ°5 -> Tech-enriched Future

Expected Growth : 9.9 %

What the company do ?

Tech-enriched Future from IP Group Plc refers to a future where technology is deeply integrated into various aspects of life, driving innovation and economic growth.

Why we expect these perspectives ?

IP Group Plc's 9.9% growth in Tech-enriched Future is driven by increasing demand for digital transformation, rising adoption of AI and IoT, and growing need for cybersecurity. Additionally, investments in 5G and cloud infrastructure, as well as the proliferation of smart devices, are fueling growth in this segment.

Segment nΒ°6 -> Third Party Fund Management

Expected Growth : 9.9 %

What the company do ?

Third Party Fund Management from IP Group Plc: IP Group manages third-party funds, investing in innovative companies, providing a diversified portfolio and risk management for investors.

Why we expect these perspectives ?

IP Group Plc's 9.9% growth in Third Party Fund Management is driven by increasing demand for diversified investment portfolios, expansion into new markets, and strategic partnerships. Additionally, the company's expertise in intellectual property commercialization and strong relationships with universities and research institutions contribute to its growth.

Ip Group Plc Products

Product Range What is it ?
University IP Commercialisation IP Group partners with top universities to commercialise their intellectual property, providing funding, expertise and networks to turn innovative ideas into successful businesses.
Spin-out Company Formation IP Group forms spin-out companies based on university intellectual property, providing funding, management and expertise to turn innovative ideas into successful businesses.
IP Portfolio Management IP Group manages a portfolio of intellectual property, providing strategic guidance and expertise to maximise the value of IP assets.
Licensing and Partnerships IP Group licenses intellectual property to industry partners, providing access to innovative technologies and expertise.
Funding and Investment IP Group provides funding and investment to support the development of innovative ideas and companies.

IP Group Plc's Porter Forces

IP Group Plc's patent portfolio and intellectual property rights provide a moderate barrier to entry for substitutes, but the increasing trend of open innovation and collaborative R&D may reduce the switching costs for customers.

IP Group Plc's customers, primarily universities and research institutions, have limited bargaining power due to the specialized nature of IP Group's services and the lack of alternative providers.

IP Group Plc has a diverse supplier base, and the company's specialized services reduce the bargaining power of suppliers, making it difficult for them to negotiate better prices or terms.

The threat of new entrants is high due to the increasing trend of open innovation and collaborative R&D, which reduces the barriers to entry for new players in the intellectual property management and commercialization industry.

The intensity of rivalry in the intellectual property management and commercialization industry is moderate, with a few established players competing for market share, but IP Group Plc's strong brand reputation and diversified services help to mitigate the competitive pressure.

Capital Structure

Value
Debt Weight 11.54%
Debt Cost 3.95%
Equity Weight 88.46%
Equity Cost 10.78%
WACC 9.99%
Leverage 13.04%

Historical Valuation

Price/Earnings Ratio

Margin Valuation

Peers Valuation

Competitors

Company Rational
COMB.BR Compagnie du Bois Sauvage S.A., an investment holding company, invests in the industrial and real estate sectors in Belgium. The company was incorporated in 1957 and is based in Brussels, …
MCAP.ST MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in …
BBN.SW Bellevue Group AG provides asset management services in Switzerland, the Great Britain, Germany, and internationally. The company offers a range of products in the areas of specialized healthcare equity, selected …
B8A.DE BAVARIA Industries Group AG, an industrial holding company, acquires and manages investments primarily in manufacturing and industrial service sectors in Germany. It engages in civil engineering and rails, business services, …
BRK.L Brooks Macdonald Group plc, through its subsidiaries, provides a range of investment and wealth management services to private clients, pension funds, professional intermediaries, and trustees in the United Kingdom and …

Peers Metrics

DCF BETA

Parameters

Short Term Growth
Short term Time
Long-Term Growth
WACC
Target Price
0.51$
Current Price
0.51$
Potential
-0.00%

Expected Cash-Flows

Scoring Insights

Peers Group Analysis

πŸ₯‡

Bellevue Logo
Bellevue
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

πŸ₯ˆ

Bois Sauvage Logo
Bois Sauvage
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

πŸ₯‰

Brooks Macdonald Logo
Brooks Macdonald
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

4

MedCap Logo
MedCap
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

5

IP Group Logo
IP Group
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

6

BAVARIA Logo
BAVARIA
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->